<DOC>
	<DOC>NCT02725710</DOC>
	<brief_summary>This is a randomized controlled double-blind placebo-controlled trial evaluating the impact of gabapentin given preoperatively on perioperative pain scores for women receiving uterine aspiration between 6 and 14+6 weeks gestation. This study will be a trial included in a prospective meta-analysis evaluating the use of gabapentin on perioperative pain in the abortion setting.</brief_summary>
	<brief_title>Gabapentin as an Adjunct to Perioperative Pain Management Regimens for Uterine Aspiration</brief_title>
	<detailed_description />
	<mesh_term>Abortion, Spontaneous</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Women &gt;=18 yearsold Presenting for a surgical abortion No contraindication to outpatient abortion No contraindication to gabapentin Fluency in English and able to provide informed consent Allergy, sensitivity or contraindication to gabapentin Severe renal disease Currently using gabapentin or pregalabin</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>uterine aspiration</keyword>
</DOC>